STAT Plus: Colorado board decides a pricey Novartis medicine is unaffordable
Novartis
Novartis is a pharmaceutical and biotechnology giant based in Basel, Switzerland and Cambridge, Mass. It has more than 100,000 employees and revenue in excess of $50 billion annually. Here’s a roundup of STAT coverage.
Latest
STAT Plus: Will Geron be acquired? The long-short view
STAT Plus: Novartis is flashing warning signs about the fate of its newly acquired myelofibrosis drug
STAT Plus: Novartis sues Maryland over the role of contract pharmacies in a U.S. drug discount program
STAT Plus: Listen: Controversial brain tissue research, obesity drug sales, and Novartis’ M&A drama
STAT Plus: New, serious safety risk related to MorphoSys’ cancer drug complicates, potentially threatens, Novartis acquisition
STAT Plus: A looming cancer vaccine test for Gritstone Bio, and pushback about Novartis-MorphoSys
STAT Plus: Why Novartis is going to walk away from its acquisition of MorphoSys
All Coverage
advertisement
